Bariatric Surgery Candidate, Obesity, Morbid
Conditions
Brief summary
Bariatric surgery registry for quality control and investigational purposes.
Interventions
PROCEDUREbariatric surgery
All bariatric procedures
Sponsors
Sheba Medical Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* morbid obesity
Exclusion criteria
* unfit for surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Surgery type | 10 years | Sleeve gastrectomy or Roux-Y gastric bypass (RYGBP) or Single anastomosis gastric bypass (SAGB) or biliopancreatic diversion (BPD/DS) or single anastomosis duodeno-ilial bypass (SADI) |
| Percent total weight loss (%TWL) | 1 year from surgery | \[(Weight at time of surgery - Weight at time point)/Weight at time of surgery\]X100 |
| Percent BMI loss (%BMIL) | 1 year from surgery | \[BMI at time of surgery - BMI at time point)/BMI at time of surgery\] X 100 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Co-morbidity resolution | 1 year from surgery | Cessation of medication/s used to treat weight-related co-morbidities (i.e. diabetes mellitus type 2, hypertension, dyslipidemia, degenerative joint disease etc.) |
| 30 day morbidity/mortality | up to 30 days from intervention | 30 day morbidity/mortality according to Clavien Dindo criteria |
| long-term morbidity/mortality | 31 days to 10 years from surgery | morbidity/mortality according to Clavien Dindo criteria after 30 days |
Countries
Israel
Outcome results
None listed